Vaccines R&D-2017 Featured Speakers
Michael J Lacy, Emergent BioSolutions Inc, USA
Title: Use of guinea pig anti-MVA antisera to theorize insights into MVA antigenicity in a vaccine platform
Shahin Gharakhanian, Cambridge Innovation Center, USA
Title: Critical review of Therapeutic Vaccines for the functional cure of the HIV Infection: lessons learned within clinical development programs, 2011-2017
Esther Wenzel, Technische Universität Braunschweig, Germany
Title: Fighting Pathogens and Toxins with human and human-like recombinant Antibodies
Farshad Guirakhoo, GeoVax, Inc., USA
Title: Development of novel and safe single-dose vaccines; preclinical efficacy data for zika, ebola and lassa fever
Giulio Philip Tarro, Fondazione de Beaumont Bonelli per le ricerche sul cancro, Italy
Title: Tumor liberated protein (TLP) as potential vaccine for lung cancer patients
Nora Dellepiane, Serum Institute of India, Switzerland
Title: Challenges for vaccine regulation
Stephen Albert Johnston, The Biodesign Institute ASU, USA
Title: A new source of neoantigens offers new approaches to personal and preventative cancer vaccines
Ann M. Ginsberg, AERAS, USA
Title: Turning a Corner? Progress in Tuberculosis (TB) Vaccine Development
Marjorie Robert-Guroff, National Cancer Institute, USA
Title: A sex bias in SIV vaccine protective efficacy: implications for HIV vaccine development
Barbara K. Felber, National Cancer Institute, USA
Title: Approaches to improve HIV vaccine prospects
Yvonne Saenger, New York Presbyterian Hospital, USA
Title: Immune Biomarker in Early Stage Melanoma
Laurent M. Humeau, Inovio Pharmaceuticals, USA
Title: Advances in DNA Vaccine Developments
Sophie Barreteau, VitamFero SA, French
Title: Efficacyof liveattenuatedvaccine topreventabortiondue toNeosporacaninumin ruminants
Gustavo Moreira, Technische Universität Braunschweig, Germany
Title: A vaccine pipeline: phage display for identification of vaccine candidates, and for generation of human antibodies for diagnostics and therapy
George N. Pavlakis, National Cancer Institute, USA
Title: DNA and protein co-delivery vaccines can delay SIV/SHIV acquisition in macaques
Edmund J. Gosselin, Albany Medical College, USA
Title: Adjuvant-Independent Intranasal Vaccination Via Human FcgmmaRI-Targeted Fusion Protein
Kristina De Paris, UNC at Chapel Hill, USA
Title: The road to a pediatric HIV vaccine
Shiladitya DasSarma, University of Maryland School of Medicine, USA
Title: Antigen display and therapeutic potential of a buoyant VLP-like nanoparticle
Fusataka Koide, Southern Research, USA
Title: Emerging and Re-emerging Mosquito-Borne Infectious Diseases – The Role of Non-human Primate Models in Vaccine Development
Gunnveig Grødeland, University of Oslo and Oslo University Hospital, Norway
Title: APC-targeting of antigen for increased efficacy of vaccination
James Moon, University of University of Michigan, USA
Title: Nanodisc platform for personalized neo-antigen vaccination
Mario Skiadopoulos, Emergent Biosolutions, USA
Title: Comparative Analysis of the Antibody Threshold of Protection for the Licensed Biothrax Anthrax Vaccine and Other Novel Anthrax Vaccine Candidates
Ahmed Bouzidi, Vaxeal Group, Switzerland
Title: Pre-Clinical Development Of SVX-1 : A Novel Therapeutic Cancer Vaccine
Ruth Ruprecht, Texas Biomedical Research Institute, USA
Title: HIV/AIDS vaccine development: Defending the frontline
Jay Bream, Johns Hopkins University, USA
Title: Heterotypic T cell responses to inactivated and live attenuated seasonal influenza vaccines
Mei Cong, Promega Corp, USA
Title: Reporter Bioassay and Vaccine Development
Klaus Überla, University Hospital Erlangen, Virology Institute, Germany
Title: Blocking HIV infection of the first cell in non-human primates by passive immunization
Spyros Kalams, Vanderbilt University Medical Center, USA
Title: New Technologies to evaluate vaccine-induced immune responses
Nicolas Çuburu, National Cancer Institute, USA
Title: Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins
Jasmin Leshem, National Cancer Institute, USA
Title: Combining Local Immunotoxins Targeting Mesothelin with CTLA-4 Blockade Eradicates Murine Cancer by Promoting Anti-Cancer Immunity
Mahin Khatami, National Cancer Institute (retired), USA
Title: Analyses of Data on Pathogen-Specific Vaccines: Weakening or Promoting Immunity?
Ewan Plant, US Food & Drug Administration, USA
Title: How the annual influenza vaccination affects the antibody response to drifted viruses
Amy Rosenberg, US Food & Drug Administration, USA
Title: Rescue of T cell Mediated Vaccine Immunity following Sublethal Irradiation
Scot Roberts, Altimmune, Inc., USA
Title: New approaches to prophylactic and therapeutic vaccines
Jerald Sadoff, Janssen Vaccines & Prevention B.V., The Netherlands
Title: The potential and challenges for developing a Universal Flu Vaccine
Michael A. Egan, Profectus Biosciences, Inc., USA
Title: Development of the VesiculoVax™-vectored Vaccine Platform to Rapidly Respond to New Epidemic Diseases
Purnima Dubey, The Ohio State University
Title: Reshaping acellular pertussis vaccine-induced immune responses by the novel adjuvant, BcfA
Paul Keller, FDA - CBER, USA
Title: Identification of HIV-1 gp41 Residues that Modulate Envelope CD4 Reactivity
Andrea L. Cox, Johns Hopkins University, USA
Title: How close are we to realizing a hepatitis C vaccine- and do we need one?
Adan Rios, University of Texas Medical School in Houston, USA
Title: Fundamental challenges to the development of an HIV vaccine
Richard Wyatt, Scripps Institute in La Jolla, CA, USA
Title: HIV Env trimer immunogen design and modification to elicit neutralizing antibodies
Graham Pawelec, University of Tuebingen, Germany
Title: Immune frailty: role of viral infection and impact on vaccination in the elderly
Yongjun Sui, National Cancer Institute, USA
Title: Orally delivered mucosal vaccine targeting colorectal immunity protected SHIV transmission in macaques
Klaus Schwamborn, Valneva, France
Title: Responding to the threat of emergent infectious diseases
Yoshikazu Kurosawa, Fujita Health University, Japan
Title: Analysis of antibody repertoires induced by vaccination with four kinds of H5N1 viruses in twenty volunteers
Laura Hong, Merck, USA
Title: Pivotol role of cellular necrosis in residual cytotoxicity of a recombinant vaccine against Clostridium Difficile
Danushka Kumara Wijesundara, The University of Adelaide, Australia
Title: Cytolytic DNA vaccine to induce antigen cross-presentation by dendritic cells and liver tissue resident memory CD8+ T cells
Adan Rios, The George McGovern Medical School at Houston Texas, USA
Title: Fundamental challenges to the development of an HIV vaccine
J. Brian Kimble, University of Texas Medical Branch, USA
Title: Deconvolution of neutralizing antibody response induced by a trivalent parainfluenza-vectored ebolavirus vaccine
Murillo Silva, Northeastern University, USA
Title: Elimination of immunodominant B cells drives the germinal center reaction toward subdominant epitopes: A potential vaccination strategy to target broadly neutralizing epitopes
Thomas Kieber-Emmons, University of Arkansas for Medical Sciences, USA
Title: Targeting Tumor Associated Carbohydrate Antigens for Cancer Therapy
Peter Johannes Holst, University of Copenhagen, Center of Medical Parasitology, ISIM, Denmark
Title: Mucosal vaccination with accessory antigens provides surprisingly robust protection against early SIV replication. Underappreciated role of location and immunodominance in vaccination against chronic infection?
Trudy G Morrison, University of Massachusetts Medical School, USA
Title: The Importance of RSV F Protein Conformation In Stimulation of Neutralizing Antibodies in Mice Previously Infected with RSV
Franklin R. Toapanta, Universityf of Maryland, USA
Title: T cell-mediated immune responses induced by the oral live-attenuated Shigella vaccine candidate CVD 1208S in humans
Adan Rios, The George McGovern Medical School at Houston Texas, USA
Title: Fundamental challenges to the development of an HIV vaccine
J. Patricia Dhar, Wayne State University School of Medicine, USA
Title: The safety and immunogenicity of Quadrivalent HPV (qHPV) vaccine in systemic lupus erythematosus
Rachel J Stephenson, The University of Queensland, Australia
Title: Systematic evaluation of self-assembling and self-adjuvanting lipopeptide vaccine candidates for the induction of protective immune responses
Matthew Woodling, Merck & Co., Inc, USA
Title: Overcoming Bioprocess Research and Development Hurdles to Advance an LVV Candidate for Human Cytomegalovirus
Gordon Harkiss, MV Diagnostics Ltd, UK
Title: Immune responses to Mycobacterium bovis in naturally infected ruminants
Jessica A. White, PATH, USA
Title: Stability improvements to subunit and live attenuated influenza vaccines
Shengqing Yu, Chinese Academy of Agricultural Sciences, China
Title: Characterization and cross-protection evaluation of M949_1603 gene deletion Riemerella anatipestifer mutant RA-M1
Ling Chen, Guangzhou Medical University, China
Title: A HIV vaccine based on MTVV prime Adv boost controlled viral reservoir and conferred long-term protection from SIVmac239 infection
Yuetsu Tanaka, University of the Ryukyus, Japan
Title: Toward developing antibody-drugs for prophylaxis of HTLV-I infection and onset of Adult T-cell Leukemia (ATL)
James J. Moon, University of Michigan, USA
Title: Nano-vaccine platform technology for personalized cancer vaccination
Title: Initial and long-term stability study of Pfs230-EPA conjugates adjuvanted with Alhydrogel®
Yanmin Wan, Nebraska Center for Virology, USA
Title: Resident humoral response elicited by repeatedly same site inoculations inhibits systemic immunity of gene based vaccines
Yasuhiro Yasutomi, Tsukuba Primate Research Center, Japan
Title: Recombinant BCG expressing SOCS1 antagonist as a novel BCG vaccine
Jianping Li, University of Connecticut, USA
Title: Novel Universal Nanoparticle Vaccines for Bird Flu and Coronavirus Infections in Birds
Jasmin Leshem, National Cancer Institute, USA
Title: Combining Local Immunotoxins Targeting Mesothelin with CTLA-4 Blockade Synergistically Eradicates Murine Cancer by Promoting Anti-Cancer Immunity
Michael G. Hanna, Vaccinogen Inc., USA
Title: A key to the backdoor into the castle: The clinical ramifications of immunoediting driven by antigenic competition
Roy Curtiss III, University of Florida, USA
Title: Vaccine design to safely induce protective immunity of long duration
Bernadette Ferraro, Inovio Pharmaceuticals, Inc., USA
Title: Synthetic Immunogens Drive Potent Antigen Specific Anti-Tumor Immune Responses
Jagannadha Sastry, The MD Anderson Cancer Center, Houston, TX
Title: Curative efficacy of therapeutic mucosal HPV E6/E7 peptide vaccination combined with checkpoint modulation in preclinical mouse models of HPV+ genital and oral cancers
Jonathan Abraham, Brigham & Women's Hospital/Harvard Medical School, USA
Title: Vaccine elicited broadly neutralizing antibodies against New World hemorrhagic fever arenaviruses
Jay A. Berzofsky, National Cancer Institute, USA
Title: Translation of cancer vaccines from mice to human clinical trials
Betsy C. Herold, Albert Einstein College of Medicine, USA
Title: Herpes Simplex Virus (HSV) DgD-2 Vaccine Elicits High Titer FcgR Activating Antibodies and Prevents Primary Infection and Latency in Multiple Small Animal Models
Stephanie M. Dorta-Estremera, MD Anderson Cancer Center, USA
Title: Enhancing the therapeutic efficacy of mucosal HPV E6/E7 peptide vaccination with checkpoint modulation in preclinical mouse models of HPV+ oral cancers
Shi-Hua Xiang, University of Nebraska-Lincoln, USA
Title: Stabilization of gp120 outer domain for HIV vaccine immunogen design
Isabel Yee Pinn Tsin, Sunway University, Malaysia
Title: Characterization of significant molecular determinants of virulence of Enterovirus 71 sub-genotype B4 in Rhabdomyosarcoma cells
Christine E. Ferragine, Biologics Resources LLC, USA
Title: Conjugate rPA-PGA anthrax vaccine induces protective antibodies
Tracy Scott, Pfizer, Inc., USA
Title: Process development of a glycoconjugate vaccine
Lihua Wang, Kansas State University, USA
Title: Recombinant porcine reproductive and respiratory syndrome virus strain P129 expressing CSFV E2 glycoprotein enhanced pathogenesis of CSFV in pigs
Rachel Madera, Kansas State University, USA
Title: Development of a one-dose classical swine fever sub-unit vaccine
Yulia Burakova, Kansas State University, USA
Title: Combination adjuvants in subunit veterinary vaccines
Jean Boyer, Inovio Pharmaceuticals, USA
Title: Systems and standard immunology demonstrated a prophylactic intradermal delivery of INO-4201 drives robust Ebola glycoprotein specific humoral and cellular immune responses in healthy volunteers in an open label phase I trial
Maryann Giel-Moloney, Sanofi Pasteur, USA
Title: A split, inactivated influenza virus vaccine containing an engineered H5 hemagglutinin elicits broadly protective antibodies
Tom H. Jin, IDT Biologika, USA
Title: Age to end dreadful diseases (HIV, Malaria, TB, cancer and more): A theory of Intact or Protected Complement (IPC) immunity
Constantinos Petrovas, Vaccine Research Center, NIAID, NIH, USA
Title: Imaging of germinal center immune dynamics: Applications in vaccine development
Mark T. Esser, MedImmune, USA
Title: Pre-vaccination baseline levels of F-specific IgG and palivizumab epitope-specific antibodies predicted vaccine efficacy and failure
Madhu Gupta, Post Graduate Institute of Medical Education and Research, India
Title: Seroprevalence of measles among children aged 5-10 years in Chandigarh, North India
Mark Tomai, 3M Drug Delivery Systems, USA
Title: 3M’s hollow microneedle system and toll-like receptor 7/8 agonist 3M-052 for enhancing vaccine effectiveness
Li Shi, Shanghai Zerun Biotechnology Co .,Ltd., China
Title: Vaccine research and development in china: Status of product development and regulatory land scope
Anuj Sharma, Uniformed Services University of the Health Sciences, USA
Title: Novel inactivated-alphavirus vaccine candidates
Jennifer A. Schwartz, Profectus BioSciences, Inc., USA
Title: Development of the VesiculoVax™ vaccine platform to rapidly respond to new epidemic diseases
Marie-Claire Gauduin, Texas Biomedical Research Institute, USA
Title: Efficacy of Novel Epithelial Stem Cell-based AIDS Vaccine to Induce Mucosal Immune Responses and Protect against SIV Challenge in Macaques
Caroline T Tiemessen, University of the Witwatersrand, South Africa
Title: Host genetic variability and HIV vaccines: a focus on low affinity Fcγ receptors
Marc Van Regenmortel, University of Strasbourg, France
Title: Developing a preventive HIV vaccine requires solving inverse problems which is not feasible by rational vaccine design
Pirouz Daftarian, MBL International, USA
Title: A rapid platform / assay for immunogenicity testing of cancer (neo)epitopes amenable to predict responders from non-responders